Time-dependent systolic and diastolic function in mice overexpressing calcineurin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Semeniuk, L M ^a   Severson, D L ^a   Kryski, A J ^a   Swirp, S L ^a   Molkentin, J D ^b   Duff, H J ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Heart failure; Hemodynamics; Hypertrophy; Left ventricular; Sudden death; Ultrasound

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; GENE PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SUDDEN DEATH; SYSTOLE; TIME SERIES ANALYSIS; TRANSGENIC MOUSE;

EID: 0037305042     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00546.2002     Document Type: Article

References (22)

1. Banijamali HS, ter Keurs MH, Paul LC, and ter Keurs HE. Excitation-contraction coupling in rat heart: influence of cyclosporin A. Cardiovasc Res 27: 1845-1854, 1993.
2. Bland JM and Altmann DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet 1: 307-310, 1986.
3. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997.
4. Georgakopoulos D and Kass DA. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol 534: 535-545, 2001.
5. Hoit BD, Khoury SF, Kranias EG, Ball N, and Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 77: 632-637, 1995.
6. Lim HW, DeWindt L, and Molkentin JD. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J Mol Cell Cardiol 32: 697-709, 2000.
7. Meguro T, Hong C, Asai K, Takagi G, McKinsey TA, Olson EN, and Vatner SF. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res 84: 735-740, 1999.
8. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, and Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
9. Oberst L, Zhao G, Park JT, Brugada R, Michael L, Entman ML, and Roberts R. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. J Clin Invest 102: 1498-1505, 1998.
10. Ohno M, Cheng CP, and Little WC. Mechanisms of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 89: 2241-2250, 1994.
11. Patterson SW, Piper H, and Starling EH. The regulation of the heart beat. J Physiol 48: 465-513, 1914.
12. Semeniuk LM, Kryski AJ, and Severson DL. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am J Physiol Heart Circ Physiol 283: H976-H982, 2002.
13. Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H, Kudoh S, Shibasaki F, Yazaki Y, Nagai R, and Komuro I. Calcineurin plays a critical role in pressure overloadinduced cardiac hypertrophy. Circulation 100: 2449-2454, 1999.
14. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, and Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281: 1690-1693, 1998.
15. Taffet GE, Hartley CJ, Wen X, Pham T, Michael LH, and Entman ML. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am J Physiol Heart Circ Physiol 270: H2204-H2209, 1996.
16. Takeishi Y and Walsh RA. Cardiac hypertrophy and failure: lessons learned from genetically engineered mice. Acta Physiol Scand 173: 103-111, 2001.
17. Takuma S, Suehiro K, Cardinale C, Hozumi T, Yano H, Shimizu J, Mullis-Jansson S, Sciacca R, Wang J, Burkoff D, Di Tullio MR, and Homma S. Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol 280: H2364-H2370, 2001.
18. Wickenden A, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, and Backx PH. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res 37: 312-323, 1998.
19. Wiesmann F, Ruff J, Hiller KH, Rommel E, Haase A, and Neubauer S. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. Am J Physiol Heart Circ Physiol 278: H652-H657, 2000.
20. Williams RV, Lorenz JN, Witt SA, Hellard DT, Khoury PR, and Kimball TR. End-systolic stress-velocity and pressuredimension relationships by transthoracic echocardiography in mice. Am J Physiol Heart Circ Physiol 275: H1828-H1835, 1998.
21. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, and Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol Heart Circ Physiol 277: H1967-H1974, 1999.
22. 2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. J Mol Cell Cardiol 33: 249-259, 2001.